Condition: Bladder (Urothelial, Transitional Cell) Cancer · Sponsor: Ekaterina Laukhtina
The goal of this single arm, prospective, open-label, investigator-initiated Phase 2 clinical trial is to evaluate the efficacy of intravesical chemoablation in patients with low grade bladder cancer.
This description comes directly from the study's public registry record.
Ekaterina Laukhtina Dr., Medical Doctor · +43 (0)1 40400-26315 · ekaterina.laukhtina@meduniwien.ac.at
Always discuss trial participation with your own doctor first.
| Department of Urology, Medical University of Vienna | Vienna, Austria | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07019220